Diabetes Drug Class May Hold Promise for Gout Prevention

This post was originally published on this site

Sodium-glucose cotransporter-2 (SGLT2) inhibitors may reduce the risk for gout among adults with type 2 diabetes, new research suggests. The study, involving more than 200,000 individuals from a US commercial insurance database, was published online …

Click here to read full article